Merck Manual

Please confirm that you are a health care professional

Loading

Portal Vein Thrombosis

By

Whitney E. Jackson

, MD, University of Colorado School of Medicine

Last full review/revision Feb 2020| Content last modified Feb 2020
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Topic Resources

Portal vein thrombosis causes portal hypertension and consequent gastrointestinal bleeding from varices, usually in the lower esophagus or stomach. Diagnosis is based on ultrasonography. Treatment involves control of variceal bleeding (usually with endoscopic banding, IV octreotide, or both), prevention of recurrence using beta-blockers, and sometimes surgical shunts and thrombolysis for acute thrombosis.

Etiology

Common causes vary by age group (see table Common Causes of Portal Vein Thrombosis).

Table
icon

Common Causes of Portal Vein Thrombosis*

Age Group

Cause

Comments

Neonates

Umbilical stump infection, or omphalitis (spread via the umbilical vein to the portal vein)

Congenital portal vein abnormalities (less common)

Congenital abnormalities of the portal vein usually accompany congenital defects elsewhere.

Older children

Pylephlebitis

In acute appendicitis, infection enters the portal system; the vascular infection/inflammation then triggers thrombosis.

Adults

Surgery (eg, splenectomy)

Hypercoagulable states (eg, myeloproliferative disorder, protein C or S deficiency, pregnancy)

Cancer (eg, hepatocellular or pancreatic carcinoma, renal cancers or adrenal cancers)

Trauma

Possibly portal hypertension causing congestion and stasis

* The cause is multifactorial in most cases and unknown in about one third of cases.

Symptoms and Signs

Acute portal vein thrombosis is commonly asymptomatic unless associated with another event, such as pancreatitis (the cause), or another complication, such as mesenteric venous thrombosis. Most often, clinical features—splenomegaly (especially in children) and variceal hemorrhage—develop over a period of time secondary to portal hypertension. Ascites is uncommon (10%) in pre-sinusoidal portal hypertension. Ascites may be precipitated when cirrhosis is also present or when serum albumin (and thus oncotic pressure) deceases after high-volume fluid resuscitation for a major gastrointestinal bleed.

Diagnosis

  • Clinical evaluation and liver tests

  • Doppler ultrasonography

Portal vein thrombosis is suspected in patients with the following:

  • Manifestations of portal hypertension without cirrhosis

  • Mild abnormalities in liver function or enzymes plus risk factors such as neonatal umbilical infection, childhood appendicitis, or a hypercoagulability disorder

Doppler ultrasonography is usually diagnostic, showing diminished or absent portal vein flow and sometimes the thrombus. Difficult cases may require MRI or CT with contrast. Angiography may be required to guide shunt surgery.

Treatment

  • For some acute cases, thrombolysis

  • Long-term anticoagulation

  • Management of portal hypertension and its complications

In acute cases, thrombolysis is sometimes successful, best reserved for recent occlusion, particularly in hypercoagulable states. Anticoagulation does not lyse clots but has some value for long-term prevention in hypercoagulable states despite the risk of variceal bleeding. In neonates and children, treatment is directed at the cause (eg, omphalitis, appendicitis). Otherwise, management is directed at the portal hypertension and its complications; treatment can include octreotide IV (a synthetic analog of somatostatin) and endoscopic banding to control variceal bleeding and nonselective beta-blockers to prevent rebleeding. These therapies have decreased the use of surgical shunts (eg, mesocaval, splenorenal), which can become occluded and have an operative mortality rate of 5 to 50%. Transjugular intrahepatic portosytemic shunting (TIPS) has a limited role in the treatment of portal vein thrombosis (see [1]).

Treatment reference

  • Valentin N, Korrapati P, Constantino J, et al: The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: A systematic review and meta-analysis. Eur J Gastroenterol Hepatol 30(10):1187-1193, 2018.

Key Points

  • Causes of and risk factors for portal vein thrombosis include umbilical cord infection (in neonates), appendicitis (in children), and hypercoagulability states (in adults).

  • Suspect portal vein thrombosis if patients have manifestations of portal hypertension in the absence of cirrhosis or if they have mild, nonspecific liver abnormalities plus risk factors.

  • Confirm the diagnosis using Doppler ultrasonography or, if results are inconclusive, MRI or CT with contrast.

  • Treat the cause of portal vein thrombosis and the complications of portal hypertension.

Drugs Mentioned In This Article

Drug Name Select Trade
SANDOSTATIN
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest

Videos

View All
Overview of Gallstones
Video
Overview of Gallstones
3D Models
View All
Hepatic Lobules
3D Model
Hepatic Lobules

SOCIAL MEDIA

TOP